Search Results - "DONADIO, J. V"

Refine Results
  1. 1

    Predicting renal outcome in IgA nephropathy by RADFORD, M. G, DONADIO, J. V, BERGSTRALH, E. J, GRANDE, J. P

    “…Immunoglobulin A (IgA) nephropathy, the most common form of glomerulonephritis worldwide, is characterized by a heterogeneous clinical course. In this study,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Use of fish oil to treat patients with immunoglobulin A nephropathy by DONADIO, J. V

    “…This review describes the use of fish oil in the treatment of patients with immunoglobulin (Ig) A nephropathy. IgA nephropathy is the most common glomerular…”
    Get full text
    Conference Proceeding Journal Article
  4. 4

    Prognostic determinants in lupus nephritis: a long-term clinicopathologic study by Donadio, Jr, J V, Hart, G M, Bergstralh, E J, Holley, K E

    Published in Lupus (01-04-1995)
    “…Over the past 50 years, survival has improved in patients with systemic lupus erythematosus and associated nephritis. Yet, there are few long-term outcome…”
    Get more information
    Journal Article
  5. 5

    IgA Nephropathy by Donadio, James V, Grande, Joseph P

    Published in The New England journal of medicine (05-09-2002)
    “…IgA nephropathy is the most common form of primary glomerulonephritis in the world and is also the most common cause of end-stage renal disease in patients…”
    Get full text
    Journal Article
  6. 6

    Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo by Grande, Joseph P., Walker, Henry J., Holub, Bruce J., Warner, Gina M., Keller, Dawn M., Haugen, James D., Donadio, James V., Dousa, Thomas P.

    Published in Kidney international (01-03-2000)
    “…Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Mesangial cell proliferation is a characteristic feature of IgA…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    The fate of renal transplants in patients with IgA nephropathy by Frohnert, P P, Donadio, Jr, J V, Velosa, J A, Holley, K E, Sterioff, S

    Published in Clinical transplantation (01-04-1997)
    “…IgA Nephropathy (IgA N) is one of the most common glomerulopathies and may lead to renal failure in 10-20% of cases. After renal transplantation, IgA N has a…”
    Get more information
    Journal Article
  8. 8

    Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody by Fervenza, Fernando C., Terreros, Daniel, Boutaud, Ariel, Hudson, Billy G., Williams, Roy A., Donadio, James V., Schwab, Thomas R.

    Published in American journal of kidney diseases (01-09-1999)
    “…We describe the case of a 54-year-old man who first presented with a clinical syndrome manifested by recurrent pulmonary hemorrhage, hematuria, and mild renal…”
    Get full text
    Journal Article
  9. 9

    Idiopathic membranous nephropathy: The natural history of untreated patients by Donadio, James V., Torres, Vicente E., Velosa, Jorge A., Wagoner, Richard D., Holley, Keith E., Okamura, Mikio, Ilstrup, Duane M., Chu, Chu-Pin

    Published in Kidney international (01-03-1988)
    “…Idiopathic membranous nephropathy: The natural history of untreated patients. We reviewed the diagnostic features and clinical course of 140 patients with…”
    Get full text
    Journal Article
  10. 10

    Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease by Donadio, Jr, J V

    Published in Mayo Clinic proceedings (01-10-1991)
    “…Omega-3 polyunsaturated fatty acids are among new treatments being tested for efficacy in immune renal disease. The principal omega-3 polyunsaturated fatty…”
    Get more information
    Journal Article
  11. 11

    Immunosuppressive drug therapy in lupus nephritis by Donadio, Jr, J V, Glassock, R J

    Published in American journal of kidney diseases (01-03-1993)
    “…During the past two decades, the immunosuppressive drugs azathioprine and cyclophosphamide have been widely used in the treatment of patients with lupus…”
    Get more information
    Journal Article
  12. 12

    Reversible Membranous Nephropathy Associated With the Use of Nonsteroidal Anti-inflammatory Drugs by Radford, M. Gene, Holley, Keith E, Grande, Joseph P, Larson, Timothy S, Wagoner, Richard D, Donadio, James V, McCarthy, James T

    “…Objective.—To investigate the frequency of membranous nephropathy associated with nonsteroidal anti-inflammatory drug (NSAID) use and identify associated…”
    Get full text
    Journal Article
  13. 13

    A controlled trial of fish oil in IgA nephropathy by Donadio, J.V. Jr. (Mayo Clinic, Rochester, MN.), Bergstralh, E.J, Offord, K.P, Spencer, D.C, Holley, K.E

    Published in The New England journal of medicine (03-11-1994)
    “…Background. The n-3 fatty acids in fish oil affect eicosanoid and cytokine production and therefore have the potential to alter renal hemodynamics and…”
    Get full text
    Journal Article
  14. 14

    Elevated urinary excretion of the C5b-9 complex in membranous nephropathy by Schulze, Matthias, Donadio, James V., Pruchno, Charles J., Baker, Patricia J., Johnson, Richard J., Stahl, Rolf A.K., Watkins, Sandra, Martin, Donald C., Wurzner, Reinhard, Gotze, Otto, Couser, William G.

    Published in Kidney international (01-09-1991)
    “…Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. In experimental membranous nephropathy, antibody binding to glomerular epithelial…”
    Get full text
    Journal Article Conference Proceeding
  15. 15
  16. 16
  17. 17

    Proteinuria patterns and their association with subsequent end‐stage renal disease in IgA nephropathy by Donadio, James V., Bergstralh, Erik J., Grande, Joseph P., Rademcher, Diana M.

    Published in Nephrology, dialysis, transplantation (01-07-2002)
    “…Background. Proteinuria (UP) >1.0 g/24 h at diagnosis is a well‐known indicator of progressive renal disease in patients with IgA nephropathy (IgAN). To…”
    Get full text
    Journal Article
  18. 18

    Essential fatty acid deficiency profiles in idiopathic immunoglobulin A nephropathy by Holman, R T, Johnson, S B, Bibus, D, Spencer, D C, Donadio, Jr, J V

    Published in American journal of kidney diseases (01-05-1994)
    “…The profiles of fatty acids (FAs) of plasma phospholipids (the compartment reflecting the essential FA status of tissue lipids), nonesterified FAs (the…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy by Donadio, Jr, J V, Anderson, C F, Mitchell, 3rd, J C, Holley, K E, Ilstrup, D M, Fuster, V, Chesebro, J H

    Published in The New England journal of medicine (31-05-1984)
    “…Forty patients with Type I membranoproliferative glomerulonephritis were treated for one year with dipyridamole, 225 mg per day, and aspirin, 975 mg per day,…”
    Get more information
    Journal Article